Baseline serum proteomics profiling as a predictor of treatment outcome and response in hepatocellular carcinoma patients undergoing immunotherapy with atezolizumab and bevacizumab

J S Schneider, I Schwald, L S Jochheim, V Zarka, J M Schütte, S Enssle, M N Gröper, A Bulut, D Rössler, M Stechele, M Karin, K Ondrejkova, A Philipp, M Seidensticker, D Anz, A Petrera, G Beyer, A Geier, J Ricke, E N De Toni, J Mayerle, M Alunni-Fabbroni, F P… · Zeitschrift für Gastroenterologie · 2026 · Heft 08 · S. e432-e433